Drilldown: Medicines
Appearance
Medicines > fda max
:
ICS 880 mcg/d (asthma); intranasal 200 mcg/d
or
Titrated to glucose; no fixed maximum
& onset:
LDL lowering at 2 weeks, max by 4 weeks 
:
ICS 880 mcg/d (asthma); intranasal 200 mcg/d
or
Titrated to glucose; no fixed maximum
& onset:
LDL lowering at 2 weeks, max by 4 weeks 
Use the filters below to narrow your results.
There are no results for this report.

